SS Innovations International (SSII) Income towards Parent Company (2016 - 2026)
SS Innovations International (SSII) reported Income towards Parent Company of -$3.6 million for Q1 2026, up 20.18% on a YoY basis from -$3.0 million in Q1 2025, and down 165.34% sequentially from $5.5 million in Q4 2025.
SS Innovations International (SSII) Income towards Parent Company (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Income towards Parent Company data on file, last reported at -$3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company rose 20.18% year-over-year to -$3.6 million; the trailing twelve-month figure through Mar 2026 stood at -$2.1 million (down 180.5% YoY), and the FY2025 full-year result was -$8.2 million, down 1052.11% from the prior year.
- Income towards Parent Company retreated to -$3.6 million in Q1 2026, from $5.5 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $12.9 million in Q4 2024 to a low of -$9.6 million in Q4 2023.
- A 5-year average of -$1.5 million and a median of -$1.5 million in 2023 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company tumbled 1189.82% in 2023 and jumped 234.48% in 2024, its largest moves.
- Tracing SSII's Income towards Parent Company over 5 years: stood at -$998076.0 in 2022, then plunged by 861.09% to -$9.6 million in 2023, then jumped by 234.48% to $12.9 million in 2024, then tumbled by 57.5% to $5.5 million in 2025, then slumped by 165.34% to -$3.6 million in 2026.
- Business Quant data shows SSII's Income towards Parent Company at -$3.6 million in Q1 2026, $5.5 million in Q4 2025, and -$3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | SS Innovations International | 776.19 Mn | 752.58 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.58 Mn |
| Dec 31, 2025 | 5.48 Mn |
| Sep 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -256,691.00 |
| Mar 31, 2025 | -4.49 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Sep 30, 2024 | -2.56 Mn |
| Jun 30, 2024 | -3.27 Mn |
| Mar 31, 2024 | -7.77 Mn |
| Dec 31, 2023 | -9.59 Mn |
| Sep 30, 2023 | -1.50 Mn |
| Jun 30, 2023 | -4.36 Mn |
| Mar 31, 2023 | -1.04 Mn |
| Dec 31, 2022 | -998,076.00 |
| Sep 30, 2022 | -456,494.00 |
| Jun 30, 2022 | -788,423.00 |
| Mar 31, 2022 | -80,421.00 |
| Dec 31, 2021 | -352,956.00 |
| Sep 30, 2021 | -418,209.00 |
| Jun 30, 2021 | -412,314.00 |